Pharmacokinetic Study Comparing Blood Levels of Dasatinib in Healthy Participants Who Received the Tablet Formulation With Those Who Received Liquid and Tablet-dispersed Formulations

NCT01392703 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

141

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetic Study in Healthy Participants

Interventions

DRUG: Dasatinib as tablets
DRUG: Dasatinib as liquid
DRUG: Dasatinib as dispersed tablets

Sponsor

Bristol-Myers Squibb